Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of the Annual General Meeting of Embellence Group AB

The shareholders of Embellence Group AB (publ), corp. reg. no. 556006-0625 (“Embellence” or the “Company”), are hereby summoned to the Annual General Meeting on Wednesday, 8 May 2024 at 1:00 p.m. at the Company’s premises at Ryssnäsgatan 8 in Borås, Sweden.Exercise of voting rights at the Annual General MeetingShareholders who wish to participate must: i. be recorded in the share register maintained by Euroclear Sweden AB as per 29 April 2024; andii. must have notified the Company of their intention to participate at the Annual General Meeting in accordance with the instructions

Change in Kamux’s Group Management Team: Chief Sourcing Officer Juha Saarinen to leave Kamux

Kamux Corporation, Stock Exchange Release, 8.4.2024 at 11:30 Change in Kamux’s Group Management Team: Chief Sourcing Officer Juha Saarinen to leave Kamux Juha Saarinen, Kamux Corporation’s Chief Sourcing Officer and a member of the Group Management Team, has decided to leave Kamux in order to pursue a career opportunity outside of Kamux. He will continue in his current position until July 8, 2024. Country organizations will play a stronger role in sourcing and resources for international sourcing will be increased. A recruitment for international sourcing will be started immediately.

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS IV

Press releaseStockholm, 8 April 2024 P Capital today announces that, at the close of business on 31 March 2024, the Net Asset Value, per participation loan debentures of P Capital Partners IV, is EUR 82.26 for series A1. Ordinary income of EUR 2.00 per series A1 participation loan debentures will be distributed to debenture holders on 22 April 2024. P Capital Partners IV’s assets are composed of 96.5 per cent privately issued corporate loans and 3.5 per cent publicly traded corporate bonds. P Capital is an active credit investor and loan provider to Northern and Western European

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS IV B

Press releaseStockholm, 8 April 2024 P Capital today announces that, at the close of business on 31 March 2024, the Net Asset Value per participation loan debentures of P Capital Partners IV B, is EUR 80.72 for series A1 and EUR 807.55 for series B. Ordinary income of EUR 1.78 per series A1 participation loan debentures and EUR 18.10 per series B participation loan debenture will be distributed on 22 April 2024. P Capital Partners IV B’s assets are composed of 96.5 per cent private high-yield loans and 3.5 per cent of public high-yield bonds. P Capital is an active credit

GomSpace receives 20.7 MSEK in new product orders in Q1 2024

In Q1 2024, GomSpace has secured 20.7 MSEK in new product orders from customers globally. This constitutes a 50% growth in new product sales as compared to Q1 2023.GomSpace products and subsystems will contribute to projects for 29 customers globally, including France, Italy, UK, Japan, South Korea, The United States, Brazil, Canada, Bulgaria, Thailand, Singapore, Spain, Germany and the UAE. GomSpace new VP of Products Business Unit, Henrik Kalstrup comments: ”At GomSpace, we're thrilled to observe that our intensified emphasis on product sales has led to a notable uptick in product

Akobo Minerals AB (publ) - Mandatory notification of PDMR

Oslo, Norway – 08 April 2024 Hans Olav Torsen (Chairman) and Jørgen Evjen (CEO) have on 05 April 2024 transferred their shares in Akobo Minerals AB (publ) to their wholly owned companies, Hering AS and Kanoka Invest AS. -          Hans Olav Torsen transferred 500.000 shares at NOK 1 per share to Hering AS. -          Jørgen Evjen transferred 60.000 shares at NOK 1 per share to Kanoka Invest AS. Following such transfer, the primary insiders will retain an unchanged ownership and stake in the Company, thus holding the same number of shares as before. This information is subject

Notice of the AGM of Ependion AB

The shareholders of Ependion AB (publ) are hereby convened to the Annual General Meeting (AGM), which will be held on Tuesday, 14 May 2024, at 15:00 CEST at High Court, Malmöhusvägen 1, Malmö. Registration opens at 14:00 CEST. The Board of Directors has decided that the shareholders shall be able to exercise their voting rights by postal voting in accordance with the rules of the Articles of Association. It will also be possible to follow the Annual General Meeting online, on www.ependion.com, but without the opportunity to vote or ask questions. No special registration is required to

Caroline Henricson appointed as Chief Commercial Officer for Tobii Dynavox

Tobii Dynavox AB (Publ) today announced the appointment of Caroline Henricson as Chief Commercial Officer (CCO) and new member of the Executive Management Team. She will assume the position April 15, 2024. The new Chief Commercial Officer role will expand and complement Tobii Dynavox’s current executive management team . In her role as CCO, Caroline will be responsible for the following areas: · Acapela Group  (synthetic voice solutions) and Rehadapt  (mounting solutions

Invitation – SEB’s results for the first quarter 2024

On Wednesday 24 April, at approximately 07:00 CET, SEB’s results for the first quarter 2024 will be announced. In addition, presentations and the Fact Book will be available on sebgroup.com/ir . You are invited to participate in the following event: Telephone conferenceTime: 09:30 CETJohan Torgeby, SEB’s President and CEO, and Masih Yazdi, CFO, will present the results, followed by a Q&A session with Johan Torgeby, Masih Yazdi and Pawel Wyszynski, Head of Investor Relations. The presentation and Q&A will be conducted in English. To participate in the

Nederman commits to the Science Based Targets initiative (SBTi)

Nederman has committed to the Science Based Targets initiative, aiming to become a climate net-zero business by 2050 at the latest. As a world-leading environmental technology company Nederman has a position to drive positive change. Sustainability is seen as a business opportunity and the company has committed to the Science Based Targets initiative (SBTi). “We will continue to deliver strong business developments supporting our customers' needs for, clean air, co-worker health & safety, energy savings, circularity and resource use efficiency. Committing to the SBTi is another step

Aker Carbon Capture ASA: Notice of postponed Annual General Meeting with amended agenda

Reference is made to the contemplated Joint Venture with SLB announced 27 March 2024. In connection with the Joint Venture, it is deemed relevant to amend the company’s purpose. To avoid holding two general meetings within a short time period, the Board of Directors have decided to postpone the Company's annual general meeting originally scheduled for 16 April 2024 until 29 April 2024 at 10:00 (CEST) and amend the agenda for the general meeting to also include the approval of amended articles of association.In addition, the Nomination Committee has updated its proposal on the composition of

Andreas Hatzigeorgiou new President and CEO of Projektengagemang

Projektengagemang Sweden AB’s (publ) board of directors has appointed Andreas Hatzigeorgiou as new President and CEO. Andreas is currently the CEO of the Stockholm Chamber of Commerce and adjunct faculty at the KTH Royal Institute of Technology School of Architecture and the Built Environment. Andreas will assume his new role during the third quarter of 2024.- It is with great pleasure that we welcome Andreas Hatzigeorgiou to Projektengagemang. Andreas has a proven track record in change management, achieving results, and delivering growth. With his expertise and keen interest in innovation

edyoutec deepens collaboration with the publisher MAF for the mobile game King Royale

Press release April 8, 2024 edyoutec announces that it is now deepening the collaboration with MAF for the mobile game King Royale. This means that MAF will take over the complete game development and marketing of the game.After King Royale underwent a period of various tests, marketing campaigns and game updates, the game has achieved stronger KPIs. MAF now takes over the entire game development and marketing.  The new agreement sees MAF dedicate a senior team to the game development and marketing of King Royale in order to begin a scale-up phase. MAF, as long as they are the

Tobii Dynavox publishes Annual Report 2023

Tobii Dynavox AB (Publ) today published the Annual Report for 2023 on the Tobii Dynavox Investor Relations website . The document also includes Tobii Dynavox sustainability report and corporate governance report. The Swedish Annual Report is also available in a European Single Electronic Format (ESEF).   Fredrik Ruben, CEO of Tobii Dynavox, commented: “I’m proud to share that Tobii Dynavox had our most successful year yet. I’m energized that it comes as a result of our team scaling the business more effectively, which demonstrates that we can

CEO of Alisa Bank Plc on Sick Leave

ALISA BANK PLC STOCK EXCHANGE RELEASE 8.4.2024 AT 10.30 EESTAlisa Bank Plc's CEO Teemu Nyholm will be on sick leave for the time being due to sudden seizure. During the sick leave, Deputy CEO, Director responsible for personal customers Juha Saari will assume the duties of the CEO. More information Markku Pohjola, Chairman of the Boardmarkku.pohjola@alisapankki.fitel. + 358 50 1654 Alisa Bank in brief Alisa Bank Plc is a Finnish digital bank  that helps both personal and business customers to manage their

OncoZenge Announces Dr. Paolo Bossi as New Member of the Advisory Board

Stockholm, Sweden – April 8 2024 – OncoZenge AB (publ), a leading pharmaceutical company developing BupiZenge™, an innovative, non-opioid treatment for oral pain, today announces that Dr. Paolo Bossi joins its Advisory Board.The OncoZenge Advisory Board was established in December 2023 with the objective of supporting the company in its efforts to lead BupiZenge™ through clinical development, market introduction and commercialization, with Dr Stephen Sonis and Dr Pooja Nandwani Patel as founding members. The company is pleased to now welcome Dr Paolo Bossi, Medical Oncologist and

BioStock: Abliva’s mission to become mitochondrial medicine powerhouse

Abliva’s CMO Magnus Hansson attended the 8[th] annual meeting of Mitochondrial Medicine – Therapeutic Development in March. The conference brings together leaders in translational mitochondrial medicine to discuss recent advances in the area of mitochondrial research and clinical development. BioStock spoke with Hansson to better understand how scientific meetings like this one fit into the company’s overall missionRead the article at biostock.se: Abliva’s mission to become mitochondrial medicine powerhouse - BioStock This is a press

NIB finances Latvia’s air traffic navigation investments

The Nordic Investment Bank (NIB) has signed a nine-year loan with Latvian air transport infrastructure company Latvijas Gaisa Satiksme (LGS) to co-finance its 2024–2026 investment programme for air navigation advances.The EUR 25 million loan has been provided to upgrading and expanding the air traffic control systems, including the construction of a new Air Traffic Control (ATC) Tower and an advanced air navigation system. These enhancements will improve air traffic control safety, reduce fuel consumption, lower emissions and minimise noise, aligning with the objectives of the European

AddSecure expands ISO 27001 certification

The internationally recognized certification demonstrates AddSecure’s continued commitment to Information Security.AddSecure  today announced that the company has successfully expanded the scope of its ISO 27001 certification (ISO/IEC 27001:2022) to include the entire Smart Alarms business unit’s operations across Europe and all corporate functions within the Group. This adds to the existing certification of the Management Systems supporting its Smart Transport business unit’s operations in the UK and its Smart Mobility business unit’s operations in the

Read original

Peikko expands its factory in Ras Al Khaimah, United Arab Emirates

Peikko Gulf LLC will increase its manufacturing capacities by 30-40% in its Ras Al Khaimah, United Arab Emirates location. The expansion includes a long-term leasing of an 11,000 m[2] adjacent land plot, an expansion of the existing factory buildings, and several new machineries. The expansion is estimated to be fully operational during Q3/2024. Peikko Gulf manufactures in Ras Al Khaimah both precast connections and DELTABEAM[®] Composite Beams with its staff of some 100 persons. Peikko’s offering in the Middle East is unique, and with opportunities given by the expanded

Notice of Annual General Meeting in CTEK AB (publ)

CTEK AB (publ), Reg. No. 559217-4659, with its registered office in Hedemora, Sweden, gives notice of the Annual General Meeting to be held on 15 May 2024 at 15:00 CEST in Convendum’s premises at Vasagatan 16, SE-111 20 Stockholm, Sweden. Registration starts at 14:30 CEST.Right to participate in the Annual General Meeting and notice of participation Participation in the Annual General Meeting at the venue A shareholder who wishes to participate in the Annual General Meeting at the venue in person or represented by a proxy must (i) be recorded as a shareholder in the share register

Elypta interim study LEVANTIS-0087A results show glycosaminoglycan's potential to predict the risk of developing any cancer with a simple urine test

The results will be presented at the 2024 American Association for Cancer Research Annual Meeting Stockholm, April 8, 2024: Swedish early cancer detection company Elypta announces that the interim results from the LEVANTIS-0087A study will be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego during the Biomarker-Based Screening session on April 9 (1:30 - 5:00 PM PT).The population-based case-control study included 2,054 adults over the age of 18 with no symptoms of cancer from the Lifelines Cohort Study in the Netherlands. The results

Caverion to deliver building solutions for new chalets in Himos, ski destination in Central Finland

Caverion Corporation Investor News 8 April 2024 at 10:00 EETCaverion to deliver building solutions for new chalets in Himos, ski destination in Central Finland The Finnish retail chain Osuuskauppa Keskimaa has selected Caverion to implement the building solutions for the holiday apartments and restaurant to be built in Himos, Central Finland. [Image: Arkkitehtipalvelu] "Our services being built at Himos will definitely attract more people to visit Himos and increase tourism in Central Finland. The project will also have a very significant impact on employment in the current downturn

Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the Company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 16/760,910 entitled “Use of NOX Inhibitors for Treatment of Cancer”.  This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed.The allowed claims cover a method of treating a solid tumor presenting resistance to PD-1 inhibitor immunotherapy by administering setanaxib in combination with a PD-1

There are no items matching the current filter
There are no more items matching the current filter
Back to top